The biology of natural killer cells in cancer, infection, and pregnancy

被引:88
作者
Miller, JS [1 ]
机构
[1] Univ Minnesota, Ctr Canc, Div Hematol Oncol & Transplantat, Dept Med, Minneapolis, MN 55455 USA
关键词
D O I
10.1016/S0301-472X(01)00696-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. NK cells are important cells of the immune system. They are ultimately derived from pluripotent hematopoietic stem cells. NK cell cytotoxicity and other functions are tightly regulated by numerous activating and inhibitory receptors including newly discovered receptors that selectively recognize major histocompatibility complex class I alleles. Based on their defining function of spontaneous cytotoxicity without prior immunization, NK cells have been thought to play a critical role in immune surveillance and cancer therapy. However, new insights into NK cell biology have suggested major roles for NK cells in infection control and uterine function. The purpose of this review is to provide an update on NK cell function, ontogeny, and biology in order to better understand the role of NK cells in health and disease. Data Sources. In the Medline database, the major subject heading "Natural Killer Cells" was introduced in 1983, identifying 16,848 citations as of December 31, 2000. Since 1986, there have been approximately 1000 citations per year under this subject heading. In this database, 68% of manuscripts are limited to human NK cells; 40% of citations cross with the major subheading of cytotoxicity, 40% with cytokines, 36% with neoplasm, 5% with antibody-dependent cellular cytotoxicity, 2.8% with pregnancy, and 1.3% with infection. Of references from the year 2000-2001, 46 were selected to combine with contributions from earlier literature. Conclusions. NK cells should no longer be thought of as direct cytotoxic killers alone as they clearly serve a critical role in cytokine production which may:be important to control cancer, infection, and fetal implantation. Understanding mechanisms of NK cell functions may lead to novel therapeutic strategies for the treatment of human disease. (C) 2001 International Society for Experimental Hematology. Published by Elsevier Science Inc.
引用
收藏
页码:1157 / 1168
页数:12
相关论文
共 151 条
[91]   Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2 [J].
Miller, JS ;
McCullar, V .
BLOOD, 2001, 98 (03) :705-713
[92]  
Miller JS, 1995, LEUKOCYTE TYPING, V1, P1431
[93]   ALTERATIONS IN SIGNAL TRANSDUCTION MOLECULES IN LYMPHOCYTES-T FROM TUMOR-BEARING MICE [J].
MIZOGUCHI, H ;
O'SHEA, JJ ;
LONGO, DL ;
LOEFFLER, CM ;
MCVICAR, DW ;
OCHOA, AC .
SCIENCE, 1992, 258 (5089) :1795-1798
[94]   Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis [J].
Moretta, A ;
Biassoni, R ;
Bottino, C ;
Mingari, MC ;
Moretta, L .
IMMUNOLOGY TODAY, 2000, 21 (05) :228-234
[95]   Role of interleukin-15 in the development of human CD56(+) natural killer cells from CD34(+) hematopoietic progenitor cells [J].
Mrozek, E ;
Anderson, P ;
Caligiuri, MA .
BLOOD, 1996, 87 (07) :2632-2640
[96]   The potential role of NK cells in the separation of graft-versus-tumor effects from graft-versus-host disease after allogeneic bone marrow transplantation [J].
Murphy, WJ ;
Longo, DL .
IMMUNOLOGICAL REVIEWS, 1997, 157 :167-176
[97]   Natural killer (NK) and T cell-associated surface marker expression following allogeneic and autologous bone marrow transplantation (BMT) [J].
Nagler, A ;
Rabinowitz, R ;
Rosengolts-Rat, J ;
Condiotti, R ;
Schlesinger, M .
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2000, 9 (01) :63-75
[98]   CONSTITUTIVE EXPRESSION OF HIGH-AFFINITY INTERLEUKIN-2 RECEPTORS ON HUMAN CD16-NATURAL KILLER-CELLS INVIVO [J].
NAGLER, A ;
LANIER, LL ;
PHILLIPS, JH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (05) :1527-1533
[99]  
NAGLER A, 1989, J IMMUNOL, V143, P3183
[100]   2B4: An NK cell activating receptor with unique specificity and signal transduction mechanism [J].
Nakajima, H ;
Colonna, M .
HUMAN IMMUNOLOGY, 2000, 61 (01) :39-43